about
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort studyNanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesCell factories for insulin productionComparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic reviewUltrasound-triggered regulation of blood glucose levels using injectable nano-network.Minimizing hypoglycemia while maintaining glycemic control in diabetesEvaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31)Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin deliveryOral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.Insulin analogues and other developments in insulin therapy for diabetes.Alternative routes of insulin delivery.New insulin analogues and their impact on diabetes care.Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries.Development of secreted proteins as biotherapeutic agents.A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes.Insulin strategies for type 2 diabetes mellitus.Insulin detemir--a new basal insulin analog.Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.How well do rapid-acting insulins work in obese individuals?Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.Achieving fasting and postprandial blood glucose control in type 2 diabetes.Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain.Perinatal outcomes associated with the use of glargine during pregnancy.Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery.Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.Challenges and advances in nanoparticle-based oral insulin delivery.Leptin gene therapy in the fight against diabetes.Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin.Basal insulin: physiology, pharmacology, and clinical implications.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Solid-state protein formulations.Issues in the provision of nursing care to people undergoing cardiac surgery who also have type 2 diabetes.Controlled release of biologics for the treatment of type 2 diabetes.Simultaneous expression and transportation of insulin by supramolecular polysaccharide nanocluster.
P2860
Q24654974-73DE0F23-82E9-4E72-8AAB-4642ED0405D9Q26779447-C94041A2-451C-4D07-B2D2-12A08A5723BCQ27000550-3FB03DE7-50DA-4B95-B88F-456A2D5D391AQ28540671-91E948E9-74FE-40E2-BCA0-CD8A9FE90E27Q30410088-8426EE8B-2810-437D-A6A3-7A8C332719BBQ30437728-456E35CC-76EC-481A-A7A9-297B2F1CFC84Q34299641-8E189044-DCD1-4564-A67F-7BC844A7863BQ34481917-7D49B9FE-B0EC-4C0D-9C50-C355551A5D93Q34532529-1002A08E-8F48-47A7-B66D-D49150E81BA6Q35164710-D140B28B-DED2-4BEB-B368-5E654366E446Q35591065-342AC3EE-1BD8-4AF2-9D46-EA3F7527F3BAQ35611319-59DB34CD-2116-4DF9-9F9E-97CE5036B65AQ35629797-C2886A2F-3964-4CB6-A109-A63A26E85CC0Q35753538-15584A58-FEA3-43D2-BAF1-270B2CBB5DD4Q35828121-4037B50D-B8C3-4BE0-B631-BC06909B4B67Q35915921-6962C3F3-ABB3-4D1E-ACC1-D7D3325C52D7Q36013053-B771A792-AEF8-4C4E-97D2-FC321E329101Q36150729-DA42618E-9C68-4897-AD0A-FDACD47D59D6Q36507652-3FAD521B-11C2-439D-9841-E38DCB7D7EA4Q36575356-9F2A5AE6-3DC0-4F72-B784-46E82C02CA67Q36636422-2F55B96A-B20A-45CF-BA02-FB023BFCCBF8Q36645386-C6D1EE6D-5C28-4FD1-A0E7-68DCEEBF0C74Q37035503-6517B324-2BC7-4C56-B16B-44F1576B8D38Q37199330-AC03C3A3-E187-49EF-B96A-084134E4B4B0Q37206883-6AFDD96C-4A69-46EE-B960-AC940DB1998FQ37235857-01D30EAA-3378-4639-836F-8E55EE155687Q37235879-BDDFBE3D-FE32-44E1-B0EC-1E6D7F3810D7Q37296843-5D26FEB1-FFE3-44BC-B70B-A54921373A08Q37371427-4F7BFBF2-33EA-4ACA-A042-42B4A0308144Q37595832-1CFA9C0C-88CA-43CA-AAC3-2148C5318390Q37632407-4B44B49B-77D4-4184-BA8C-55C22E31F255Q37778403-C8828B2E-8A50-4575-8BDF-73DCA6CA5C7EQ37826342-E0F2BED9-74FC-4F45-AD55-1E8F733C5601Q37857686-58C96CDC-5479-440C-9C41-A05E433174D8Q37890774-73A89479-5EEE-4695-8DBE-170EB0AEA053Q38195730-B2061F9B-B6C8-4234-989A-FBB22D46A7C7Q38309879-97400011-08C1-42E6-9691-7E0D8309483AQ38573431-3F75CB26-0AB4-4BE5-BECD-7009771FD58EQ38665753-F1098674-0737-4924-AC3E-794C21759D13Q38805344-ABD09BE4-9BAF-4FE9-9720-A9AEB9E75727
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insulins today and beyond.
@ast
Insulins today and beyond.
@en
Insulins today and beyond.
@nl
type
label
Insulins today and beyond.
@ast
Insulins today and beyond.
@en
Insulins today and beyond.
@nl
prefLabel
Insulins today and beyond.
@ast
Insulins today and beyond.
@en
Insulins today and beyond.
@nl
P2093
P1433
P1476
Insulins today and beyond.
@en
P2093
P304
P356
10.1016/S0140-6736(01)05842-1
P407
P577
2001-09-01T00:00:00Z